155 related articles for article (PubMed ID: 29998162)
1. Lymphoproliferative Disorders in Inflammatory Bowel Disease Patients: Is It the Drugs or the Disease.
Bernardes C; Russo P; Carvalho D; Saiote J; Ramos J
GE Port J Gastroenterol; 2018 Jun; 25(4):175-178. PubMed ID: 29998162
[TBL] [Abstract][Full Text] [Related]
2. Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review.
Subramaniam K; D'Rozario J; Pavli P
J Gastroenterol Hepatol; 2013 Jan; 28(1):24-30. PubMed ID: 23094824
[TBL] [Abstract][Full Text] [Related]
3. [Lymphoproliferative disorders in an inflammatory bowel disease unit].
Van Domselaar M; López San Román A; Bastos Oreiro M; Garrido Gómez E
Gastroenterol Hepatol; 2010 Jan; 33(1):12-6. PubMed ID: 19889478
[TBL] [Abstract][Full Text] [Related]
4. Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications.
Subramaniam K; Cherian M; Jain S; Latimer M; Corbett M; D'Rozario J; Pavli P
Intern Med J; 2013 Dec; 43(12):1339-42. PubMed ID: 24330365
[TBL] [Abstract][Full Text] [Related]
5. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).
Magro F; Peyrin-Biroulet L; Sokol H; Aldeger X; Costa A; Higgins PD; Joyce JC; Katsanos KH; Lopez A; de Xaxars TM; Toader E; Beaugerie L
J Crohns Colitis; 2014 Jan; 8(1):31-44. PubMed ID: 23721759
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders.
Nissen LH; Nagtegaal ID; de Jong DJ; Kievit W; Derikx LA; Groenen PJ; van Krieken JH; Hoentjen F
J Crohns Colitis; 2015 May; 9(5):398-403. PubMed ID: 25740811
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle.
Sokol H; Beaugerie L
Gut; 2009 Oct; 58(10):1427-36. PubMed ID: 19749141
[TBL] [Abstract][Full Text] [Related]
8. Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease.
Chupin A; Perduca V; Meyer A; Bellanger C; Carbonnel F; Dong C
Aliment Pharmacol Ther; 2020 Oct; 52(8):1289-1297. PubMed ID: 32840893
[TBL] [Abstract][Full Text] [Related]
9. The Complex Relationship between Mechanisms Underlying Inflammatory Bowel Disease, Its Treatment, and the Risk of Lymphomas: A Comprehensive Review.
Stasik K; Filip R
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673824
[TBL] [Abstract][Full Text] [Related]
10. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.
Beaugerie L; Brousse N; Bouvier AM; Colombel JF; Lémann M; Cosnes J; Hébuterne X; Cortot A; Bouhnik Y; Gendre JP; Simon T; Maynadié M; Hermine O; Faivre J; Carrat F;
Lancet; 2009 Nov; 374(9701):1617-25. PubMed ID: 19837455
[TBL] [Abstract][Full Text] [Related]
11. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
[TBL] [Abstract][Full Text] [Related]
12. Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry Study.
Guerra I; Bujanda L; Mañosa M; Pérez-Martínez I; Casanova MJ; de la Peña L; de Benito M; Rivero M; Varela P; Bernal L; Franco AC; Ber Y; Piqueras M; Tardillo C; Ponferrada Á; Olivares S; Lucendo AJ; Gilabert P; Sierra Ausín M; Bellart M; Herrarte A; Calafat M; de Francisco R; Gisbert JP; Guardiola J; Domènech E; Bermejo F;
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765708
[TBL] [Abstract][Full Text] [Related]
13. A review on co-existent Epstein-Barr virus-induced complications in inflammatory bowel disease.
Wu S; He C; Tang TY; Li YQ
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1085-1091. PubMed ID: 31205127
[TBL] [Abstract][Full Text] [Related]
14. Monitoring for Extra-Intestinal Cancers in IBD.
Sifuentes H; Kane S
Curr Gastroenterol Rep; 2015 Nov; 17(11):42. PubMed ID: 26364836
[TBL] [Abstract][Full Text] [Related]
15. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
16. [Inflammatory bowel disease and lymphoproliferative disorders].
Ye BD
Korean J Gastroenterol; 2011 Oct; 58(4):171-7. PubMed ID: 22042416
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Lymphoma in Patients with Inflammatory Bowel Disease: A Systematic Review.
Muller M; Broséus J; Feugier P; Thieblemont C; Beaugerie L; Danese S; Arnone D; Ndiaye NC; Kokten T; Houlgatte R; Peyrin-Biroulet L
J Crohns Colitis; 2021 May; 15(5):827-839. PubMed ID: 32949235
[TBL] [Abstract][Full Text] [Related]
18. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
19. Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders.
Lam GY; Halloran BP; Peters AC; Fedorak RN
World J Gastrointest Pathophysiol; 2015 Nov; 6(4):181-92. PubMed ID: 26600976
[TBL] [Abstract][Full Text] [Related]
20. Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.
Lemaitre M; Kirchgesner J; Rudnichi A; Carrat F; Zureik M; Carbonnel F; Dray-Spira R
JAMA; 2017 Nov; 318(17):1679-1686. PubMed ID: 29114832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
